Skip to main content

Aneurysm

1
Pipeline Programs
5
Companies
9
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Monoclonal Antibody
1100%
+ 8 programs with unclassified modality

Competitive Landscape

5 companies ranked by most advanced pipeline stage

UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
1
tocilizumabPhase 2Monoclonal Antibody1 trial
Active Trials
NCT05845723Recruiting81Est. Jun 2027
Medtronic
MedtronicNJ - Phillipsburg
3 programs
Axium™ MicroFX™ PGLA COILSN/A1 trial
Endurant Stent graftN/A1 trial
Pipeline™ Flex Embolization Device With Shield Technology™ Clinical StudyN/A1 trial
Active Trials
NCT01323439Completed99Est. Oct 2012
NCT01526811Completed180Est. Dec 2018
NCT02390037Completed50Est. Nov 2016
Stryker
StrykerCA - San Jose
3 programs
EffectiveNess and SAfety of Small ANeurysm COiling TrialN/A1 trial
Surpass Elite with Guardian Flow Diverter SystemN/A1 trial
Trenza Embolization Device for Intrasaccular Aneurysm TreatmentN/A1 trial
Active Trials
NCT02167997Unknown252Est. Dec 2018
NCT06872684Recruiting183Est. Jan 2031
NCT04380350Active Not Recruiting150Est. Mar 2027
Eppendorf
EppendorfGermany - Hamburg
1 program
Microsurgical Clipping of Unruptured Intracranial AneurysmN/A1 trial
Active Trials
NCT05029947Unknown3,000Est. Dec 2022
B. Braun
B. BraunGermany - Melsungen
1 program
Silver GraftN/A1 trial
Active Trials
NCT01970605Completed230Est. Dec 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
UNION therapeuticstocilizumab
StrykerSurpass Elite with Guardian Flow Diverter System
StrykerTrenza Embolization Device for Intrasaccular Aneurysm Treatment
EppendorfMicrosurgical Clipping of Unruptured Intracranial Aneurysm
MedtronicPipeline™ Flex Embolization Device With Shield Technology™ Clinical Study
StrykerEffectiveNess and SAfety of Small ANeurysm COiling Trial
B. BraunSilver Graft
MedtronicEndurant Stent graft
MedtronicAxium™ MicroFX™ PGLA COILS

Clinical Trials (9)

Total enrollment: 4,225 patients across 9 trials

NCT05845723UNION therapeuticstocilizumab

Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome

Start: Jun 2023Est. completion: Jun 202781 patients
Phase 2Recruiting
NCT06872684StrykerSurpass Elite with Guardian Flow Diverter System

Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)

Start: Jun 2025Est. completion: Jan 2031183 patients
N/ARecruiting
NCT04380350StrykerTrenza Embolization Device for Intrasaccular Aneurysm Treatment

Trenza Embolization Device for Intrasaccular Aneurysm Treatment

Start: Dec 2020Est. completion: Mar 2027150 patients
N/AActive Not Recruiting
NCT05029947EppendorfMicrosurgical Clipping of Unruptured Intracranial Aneurysm

Setting Benchmarks for Microsurgical Clipping of Unruptured Intracranial Aneurysms

Start: Jan 2016Est. completion: Dec 20223,000 patients
N/AUnknown
NCT02390037MedtronicPipeline™ Flex Embolization Device With Shield Technology™ Clinical Study

Pipeline™ Flex Embolization Device With Shield Technology™ Clinical Study

Start: Mar 2015Est. completion: Nov 201650 patients
N/ACompleted
NCT02167997StrykerEffectiveNess and SAfety of Small ANeurysm COiling Trial

EffectiveNess and SAfety of Small ANeurysm COiling Trial

Start: Nov 2013Est. completion: Dec 2018252 patients
N/AUnknown
NCT01970605B. BraunSilver Graft

Silver Graft All Comers Registry

Start: Oct 2013Est. completion: Dec 2018230 patients
N/ACompleted
NCT01526811MedtronicEndurant Stent graft

Endurant™ Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms (ENDURANT France)

Start: Mar 2012Est. completion: Dec 2018180 patients
N/ACompleted
NCT01323439MedtronicAxium™ MicroFX™ PGLA COILS

Axium™ MicroFX™ for Endovascular Repair of IntraCranial Aneurysm-A Multicenter Study

Start: Apr 2010Est. completion: Oct 201299 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 4,225 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.